Page 92 - Read Online

Page 18 of 19 van Beek et al. Microbiome Res Rep 2025;4:13 https://dx.doi.org/10.20517/mrr.2024.45

40. Marchant A, Kollmann TR. Understanding the ontogeny of the immune system to promote immune-mediated health for life. Front
Immunol 2015;6:77. DOI PubMed PMC
41. Nilsen M, Lokmic A, Angell IL, et al. Fecal microbiota nutrient utilization potential suggests mucins as drivers for initial gut
colonization of mother-child-shared bacteria. Appl Environ Microbiol 2021;87:e02201-20. DOI PubMed PMC
42. Ruas-Madiedo P, Gueimonde M, Fernández-García M, de los Reyes-Gavilán CG, Margolles A. Mucin degradation by Bifidobacterium
strains isolated from the human intestinal microbiota. Appl Environ Microbiol 2008;74:1936-40. DOI PubMed PMC
43. Lemme-Dumit JM, Song Y, Lwin HW, et al. Altered gut microbiome and fecal immune phenotype in early preterm infants with leaky
gut. Front Immunol 2022;13:815046. DOI PubMed PMC
44. Szymanska E, Wierzbicka A, Dadalski M, Kierkus J. Fecal zonulin as a noninvasive biomarker of intestinal permeability in pediatric
patients with inflammatory bowel diseases-correlation with disease activity and fecal calprotectin. J Clin Med 2021;10:3905. DOI
PubMed PMC
45. Mantis NJ, Rol N, Corthésy B. Secretory IgA’s complex roles in immunity and mucosal homeostasis in the gut. Mucosal Immunol
2011;4:603-11. DOI PubMed PMC
46. Pabst O, Slack E. IgA and the intestinal microbiota: the importance of being specific. Mucosal Immunol 2020;13:12-21. DOI PubMed
PMC
47. Fawley J, Gourlay DM. Intestinal alkaline phosphatase: a summary of its role in clinical disease. J Surg Res 2016;202:225-34. DOI
measurement of fecal calprotectin. Front Pediatr 2022;10:978545. DOI
PubMed PMC
48. Martins RDS, Kooi EMW, Poelstra K, Hulscher JBF. The role of intestinal alkaline phosphatase in the development of necrotizing
enterocolitis. Early Hum Dev 2023;183:105797. DOI PubMed
49. Malo MS. A high level of intestinal alkaline phosphatase is protective against type 2 diabetes mellitus irrespective of obesity.
EBioMedicine 2015;2:2016-23. DOI PubMed PMC
50. Lassenius MI, Fogarty CL, Blaut M, et al; FinnDiane Study Group. Intestinal alkaline phosphatase at the crossroad of intestinal health
and disease - a putative role in type 1 diabetes. J Intern Med 2017;281:586-600. DOI
51. Estaki M, DeCoffe D, Gibson DL. Interplay between intestinal alkaline phosphatase, diet, gut microbes and immunity. World J
Gastroenterol 2014;20:15650-6. DOI PubMed PMC
52. Malo MS, Moaven O, Muhammad N, et al. Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the
concentration of luminal nucleotide triphosphates. Am J Physiol Gastrointest Liver Physiol 2014;306:826-38. DOI PubMed PMC
53. Garrett WS, Onderdonk A. 249 - Bacteroides, Prevotella, Porphyromonas, and Fusobacterium Species (and other medically important
anaerobic gram-negative bacilli). In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Elsevier; 2015.
pp. 2773-80. DOI
54. Juttukonda LJ, Skaar EP. Manganese and nutritional immunity. In: Molecular, genetic, and nutritional aspects of major and trace
minerals. Elsevier; 2017. pp. 377-87. DOI
55. Nisapakultorn K, Ross KF, Herzberg MC. Calprotectin expression inhibits bacterial binding to mucosal epithelial cells. Infect Immun
2001;69:3692-6. DOI PubMed PMC
56. Heinzel S, Jureczek J, Kainulainen V, et al. Elevated fecal calprotectin is associated with gut microbial dysbiosis, altered serum
markers and clinical outcomes in older individuals. Sci Rep 2024;14:13513. DOI PubMed PMC
57. Hong L, Huang Y, Han J, et al. Dynamics and crosstalk between gut microbiota, metabolome, and fecal calprotectin in very preterm
infants: insights into feeding intolerance. Nutrients 2023;15:4849. DOI
58. Lee YM, Min CY, Choi YJ, Jeong SJ. Delivery and feeding mode affects fecal calprotectin levels in infants < 7 months old. Early
Hum Dev 2017;108:45-8. DOI PubMed
59. Kolho KL, Alfthan H. Concentration of fecal calprotectin in 11,255 children aged 0-18 years. Scand J Gastroenterol 2020;55:1024-7.
DOI PubMed
60. Sommermeyer H, Bernatek M, Pszczola M, Krauss H, Piatek J. Supporting the diagnosis of infantile colic by a point of care

61. Łoniewska B, Adamek K, Węgrzyn D, et al. Analysis of faecal zonulin and calprotectin concentrations in healthy children during the
first two years of life. An observational prospective cohort study. J Clin Med 2020;9:777. DOI PubMed PMC
62. Cekovic JR, Prodanovic NS, Mijailovic SS, et al. The perinatal factors that influence the excretion of fecal calprotectin in premature-
born children. Open Med 2022;17:1275-81. DOI
63. Zhao C, Chen N, Ashaolu TJ. Prebiotic and modulatory evidence of lactoferrin on gut health and function. J Funct Foods
2023;108:105741. DOI
64. Mastromarino P, Capobianco D, Campagna G, et al. Correlation between lactoferrin and beneficial microbiota in breast milk and
infant’s feces. Biometals 2014;27:1077-86. DOI
65. Sherman MP, Sherman J, Arcinue R, Niklas V. Randomized control trial of human recombinant lactoferrin: a substudy reveals effects
on the fecal microbiome of very low birth weight infants. J Pediatr 2016;173 Suppl:S37-42. DOI PubMed
66. González L, Sosa JLP, Mosquito S, et al. Oral lactoferrin administration does not impact the diversity or composition of the infant gut
microbiota in a Peruvian cohort. Microbiol Spectr 2023;11:e0009623. DOI PubMed PMC
67. Zilbauer M, Jenke A, Wenzel G, et al. Intestinal alpha-defensin expression in pediatric inflammatory bowel disease. Inflamm Bowel
Dis 2011;17:2076-86. DOI
68. Savilahti EM, Kukkonen AK, Haahtela T, Tuure T, Kuitunen M, Savilahti E. Intestinal defensin secretion in infancy is associated with